LETTER
Superacid Catalyzed Hydroxyalkylation of Aromatics
531
(2) (a) Filler, R.; Kobayashi, Y.; Yagupolskii, L. M.
Organofluorine Compounds in Medicinal Chemistry and
Biomedical Applications; Elsevier: Amsterdam, 1993.
(b) Ojima, I.; McCarthy, J. R.; Welch, J. T. Biomedical
Frontiers of Fluorine Chemistry; ACS Symposium Series:
Washington D. C., 1996. (c) Kukhar, V. P.; Soloshonok, V.
A. Fluorine-Containing Amino Acids, Synthesis and
Properties; Wiley: New York, 1995.
3,3,3-Trifluoro-2-hydroxy-2-(4-methylphenyl)-propion-
ic acid ethyl ester:
1H NMR (250 MHz, CDCl3): δ 1.37 (t, J = 7.2 Hz, 3 H), 2.36
(s, 3 H), 4.30 (s, -OH), 4.31–4.52 (m, 2 H), 7.21 (d, J = 8.5
Hz, 2 H), 7.67 (d, 2 H). 19F NMR (470 MHz, CDCl3): δ
–76.98. 13C NMR (125 MHz, CDCl3): δ 169.1, 139.6, 130.0,
129.1, 126.7, 123.1 (q, J = 285.5 Hz), 77.7 (q, J = 30.2 Hz),
64.3, 21.1, 13.9.
(3) (a) Lin, P.; Jiang, J. Tetrahedron 2000, 56, 3635.
(b) Prakash, G. K. S.; Yudin, K. A. Chem. Rev. 1997, 97,
757. (c) Prakash, G. K. S.; Mandal, M. J. Fluorine Chem.
2001, 112, 123; and references cited therein.
(4) (a) Nelson, D. W.; Owens, J.; Hiraldo, D. J. Org. Chem.
2001, 66, 2572. (b) Prakash, G. K. S.; Mandal, M.; Olah, G.
A. Angew. Chem. Int. Ed. 2001, 40, 589. (c) Bravo, P.;
Crucianelli, M.; Vergani, B.; Zanda, M. Tetrahedron Lett.
1998, 39, 7771. (d) Xu, Y.; Dolbier, W. R. Jr. Tetrahedron
Lett. 1998, 39, 9151.
3,3,3-Trifluoro-2-hydroxy-2-(4-methoxyphenyl)-prop-
ionic acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3 Hz), 3.82
(s, 3 H), 4.29 (s, -OH), 4.33–4.52 (m, 2 H), 6.93 (d, 1 H,
J = 9.0 Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ
–77.22 (s). 13C NMR (90 MHz CDCl3): δ 169.1, 160.5,
128.2, 124.8, 122.4 (q, J = 285.8 Hz), 113.8, 77.5 (q, J = 30.5
Hz), 64.3, 55.3, 13.9.
3,3,3-Trifluoro-2-hydroxy-2-(4-t-butylphenyl)-propionic
acid ethyl ester:
(5) (a) Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem.
1969, 34, 2543. (b) Goldberg, Y.; Alper, H. J. Org. Chem.
1992, 57, 3731.
(6) (a) Streinz, L.; Svatos, A.; Vrkoc, J.; Meinwald, J. J. Chem.
Soc., Perkin Trans. 1 1994, 3509. (b) Takahashi, T.;
Fukushima, A.; Tanaka, Y.; Segawa, M.; Hori, H.; Takeuchi,
Y.; Burchardt, A.; Haufe, G. Chirality 2000, 12, 458; and
references cited therein.
1H NMR (360 MHz, CDCl3): δ 1.32 (s, 9 H), 1.38 (t, J = 7.0
Hz, 3 H), 4.30 (s, 1 H), 4.31–4.51 (m, 2 H), 7.42 (m, 2 H),
7.70 (d, 2 H, J = 8.3 Hz). 19F NMR (338 MHz, CDCl3): δ
–76.93 (s). 13C NMR (90 MHz, CDCl3): δ 169.2, 152.7,
130.0, 126.6, 125.5, 123.2 (q, J = 285.6 Hz), 77.8 (q, J = 30.9
Hz), 64.4, 34.7, 31.3, 14.0.
3,3,3-Trifluoro-2-hydroxy-2-(4-fluorophenyl)-propionic
acid ethyl ester:
(7) (a) Dyachenko, V. I.; Kolomiets, A. F.; Fokin, A. V. J. Org.
Chem. USSR (Engl. Transl.) 1992, 28, 1345.
1H NMR (360 MHz, CDCl3): δ 1.38 (t, J = 7.5 Hz, 3 H), 4.39
(s, 1 H), 4.34–4.53 (m, 2 H), 7.09 (m, 2 H), 7.80 (m, 2 H).
19F NMR (338 MHz, CDCl3): δ –77.20 (s), –112.66 (q,
J = 9.1 Hz). 13C NMR (90 MHz, CDCl3): δ 168.75, 163.5 (d,
J = 248.8 Hz), 128.9 (dd, J = 8.6 Hz, 2.7 Hz), 128.6 (d,
J = 3.3 Hz), 122.9 (q, J = 285.7 Hz), 115.4 (d, J = 22.8 Hz),
77.4 (q, J = 30.5 Hz), 64.6, 13.8.
(b) Dyachenko, V. I.; Kolomiets, A. F.; Fokin, A. V. Izv.
Akad. Nauk, Ser. Khim. 1995, 3, 528. (c) Golubev, A. S.;
Kolomiets, A. F.; Fokin, A. V. Bull. Acad. Sci. USSR Div.
Chem. Sci.(Engl.Transl.) 1989, 38, 2180.
(8) (a) Zhuang, W.; Jorgensen, K. A. Chem. Commun. 2002,
1336. (b) Zhuang, W.; Gathergood, N.; Hazell, R. G.;
Jørgensen, K. A. J. Org. Chem. 2001, 66, 1009.
(9) Gong, Y.; Kato, K. J. Fluorine Chem. 2002, 1-5, 5735.
(10) (a) Hazeldine, R. N.; Kidd, J. M. J. Chem. Soc. 1954, 4228.
(b) Olah, G. A.; Prakash, G. K. S.; Sommer, J. Superacids;
Wiley Interscience: New York, 1985. (c) Yato, M.;
Ohwada, T.; Shudo, K. J. Am. Chem. Soc. 1991, 113, 691.
(d) Sato, Y.; Ohwada, T.; Saito, S.; Shudo, K. J. Am. Chem.
Soc. 1995, 117, 3037.
3,3,3-Trifluoro-2-hydroxy-2-(4-chlorophenyl)-propionic
acid ethyl ester:
1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.5 Hz), 4.38
(s, 1 H), 4.30–4.52 (m, 2 H), 7.39 (d, 2 H, J = 8.6 Hz), 7.75
(d, 2 H). 19F NMR (338 MHz, CDCl3): δ –77.09 (s). 13
C
NMR (90 MHz, CDCl3): δ 168.7, 136.0, 131.4, 128.7, 128.5,
122.9 (q, J = 285.9 Hz), 77.5 (q, J = 30.6 Hz), 64.8, 13.9.
3,3,3-Trifluoro-2-hydroxy-2-(2,5-dimethylphenyl)-pro-
pionic acid ethyl ester:
(11) Boumizane, K.; Herzog-Cance, M. H.; Jones, D. J.; Pascal,
J. L.; Potier, J.; Roziere, J. Polyhedron 1991, 10, 2757.
(12) Olah, G. A. Angew. Chem., Int. Ed. Engl. 1993, 32, 767.
(13) Yamazaki, T.; Saito, S.; Ohwada, T.; Shudo, K. Tetrahedron
Lett. 1995, 36, 5749.
1H NMR (360 MHz, CDCl3): δ 1.38 (t, 3 H, J = 7.3 Hz), 3.82
(s, 3 H), 4.29 (s, 1 H), 4.33–4.52 (m, 2 H), 6.93 (d, 1 H,
J = 9.0 Hz), 7.71 (d, 1 H). 19F NMR (338 MHz, CDCl3): δ
–73.65 (s). 13C NMR (90 MHz, CDCl3): δ 169.9, 135.2,
134.5, 132.5, 131.3, 129.9, 128.0 (q, J = 3.8 Hz), 123.5 (q,
J = 288.1 Hz), 79.6 (q, J = 28.8 Hz), 64.1, 21.2, 20.0, 13.8.
3,3,3-Trifluoro-2-hydroxy-2-(2,4,6-trimethylphenyl)-
propionic acid ethyl ester:
(14) New compounds were characterized by NMR (1H, 19F, 13C)
spectroscopy using Bruker AM-360 spectrometer. The
spectra were recorded in CDCl3 using TMS and CCl3F as
internal standards.
1H NMR (360 MHz, CDCl3): δ 1.26 (t, J = 7.0 Hz, 3 H), 2.18
(s, 3 H), 2.35(s, 6 H), 3.23 (s, -OH), 4.17–4.33 (m, 2 H), 6.80
2,5-Di(α-carboethoxy-a-hydroxytrifluoroethyl)-pyrrole:
1H NMR (360 MHz, CDCl3): δ 1.39 (t, J = 7.3 Hz, 6 H),
4.34–4.53 (m, 6 H), 6.44 (s, 1 H), 6.45 (s, 1 H), 9.18 (br s).
19F NMR (338 MHz, CDCl3): δ –78.92 (s). 13C NMR (90
MHz, CDCl3): δ 167.7, 122.4 (q, J = 285.5 Hz), 123.0,
122.9, 75.0 (q, J = 32.3 Hz), 64.8, 13.8.
(s, 2 H). 19F NMR (338 MHz, CDCl3): δ –76.17 (s). 13
C
NMR (90 MHz, CDCl3): δ 168.5, 137.6, 137.5, 131.2, 126.8,
123.0 (q, J = 284.8 Hz), 80.3 (q, J = 30.2 Hz), 61.7, 21.6,
21.5, 19.4, 12.6.
Synlett 2003, No. 4, 527–531 ISSN 0936-5214 © Thieme Stuttgart · New York